Senate Introduces Bill to Expand Access to Prescription Drug Information
/ 1 min read
Table of Contents
The INSPIRES Act was introduced in the U.S. Senate and read twice. It has been referred to the Committee on Health, Education, Labor, and Pensions.
Why it matters: This is an early-stage legislative action. The bill has not been voted on, passed, or signed into law. Its practical significance right now is limited to signaling the committee’s interest in drug pricing transparency. It will likely face scrutiny regarding how price data is collected and whether public disclosure could affect negotiation dynamics.
Who it affects
- Pharmaceutical manufacturers who would be required to report pricing data
This information is based on the official record from Congress.gov; readers should check the full text of the bill for specific definitions and requirements before relying on it for decision-making.
Agency: Senate
Source: Congress.gov — read the official document